Synthesis and Antimycobacterial Activity of Symmetric Thiocarbohydrazone Derivatives against Mycobacterium bovis BCG

被引:0
作者
Tehrani, Kamaleddin Haj Mohammad Ebrahim [1 ]
Kobarfard, Farzad [1 ,2 ]
Azerang, Parisa [3 ]
Mehravar, Maryam [3 ]
Soleimani, Zohreh [1 ]
Ghavami, Ghazaleh [3 ]
Sardari, Soroush [3 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Med Chem, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Phytochem Res Ctr, Tehran, Iran
[3] Inst Pasteur, Biotechnol Res Ctr, Med Biotechnol Dept, Drug Design & Bioinformat Unit, Tehran 13164, Iran
来源
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH | 2013年 / 12卷 / 02期
关键词
Thiocarbohydrazone; Thiacetazone; Mycobacterium bovis; Antifungal; In silico; DRUG-RESISTANT-TUBERCULOSIS; BRINE SHRIMP; TOXICITY ASSESSMENT; IRON CHELATORS; ARTEMIA-SALINA; THIACETAZONE; ACTIVATION; AGENTS; ETHIONAMIDE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this work, we reported the synthesis and evaluation of antimycobacterial and antifungal activity of a series of thiocarbohydrazone derivatives which are thiacetazone congeners. The target compounds were synthesized in superior yields by reacting thiocarbohydrazide with different aromatic aldehydes and methyl ketones. Compounds 8, 19 and 25 were found to be the most potent derivatives, exhibiting acceptable activity against Mycobacterium bovis BCG compared to thiacetazone and ethambutol as reference substances. Compounds 8, 15 and 25 exhibited the highest activity against Candida albicans. The most active compounds had a completely different aromatic ring system with various electronic, steric and lipophilic natures. This is understandable in light of the fact that carbohydrazone derivatives must undergo a metabolic activation step before exerting their anti-TB activity and different SAR rules govern each one of these two processes.
引用
收藏
页码:331 / 346
页数:16
相关论文
共 26 条
[1]   Thiacetazone, an Antitubercular Drug that Inhibits Cyclopropanation of Cell Wall Mycolic Acids in Mycobacteria [J].
Alahari, Anuradha ;
Trivelli, Xavier ;
Guerardel, Yann ;
Dover, Lynn G. ;
Besra, Gurdyal S. ;
Sacchettini, James C. ;
Reynolds, Robert C. ;
Coxon, Geoffrey D. ;
Kremer, Laurent .
PLOS ONE, 2007, 2 (12)
[2]  
[Anonymous], 2009, GLOBAL TUBERCULOSIS
[3]  
Baravalia Y, 2012, IRAN J PHARM RES, V11, P851
[4]   Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs [J].
Barry, CE ;
Slayden, RA ;
Sampson, AE ;
Lee, RE .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (03) :221-231
[5]   Determination of molecular properties effectuating the growth inhibition of mycobacterium tuberculosis by various small molecule hydrazides [J].
Bartzatt, Ronald ;
Cirillo, Suat L. G. ;
Cirillo, Jeffrey D. .
LETTERS IN DRUG DESIGN & DISCOVERY, 2008, 5 (03) :162-168
[6]  
Baulard AR, 2000, J BIOL CHEM, V275, P28326
[7]   Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice [J].
Bermudez, LE ;
Reynolds, R ;
Kolonoski, P ;
Aralar, P ;
Inderlied, CB ;
Young, LS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (08) :2685-2687
[8]  
BOROWITZ JL, 1992, B ENVIRON CONTAM TOX, V48, P435
[9]   METAL COMPLEXES OF THIOCARBOHYDRAZIDE [J].
BURNS, GR .
INORGANIC CHEMISTRY, 1968, 7 (02) :277-&
[10]   Activity against drug resistant-tuberculosis strains of plants used in Mexican traditional medicine to treat tuberculosis and other respiratory diseases [J].
Camacho-Corona, Maria del Rayo ;
Ramirez-Cabrera, Monica A. ;
Gonzalez-Santiago, Omar ;
Garza-Gonzalez, Elvira ;
Palacios, Isidoro de Paz ;
Luna-Herrera, Julieta .
PHYTOTHERAPY RESEARCH, 2008, 22 (01) :82-85